Galecto, Inc.

SEC filing

Biotechnology · Boston, MA

Form D on EDGAR

Amount raised$285Msold at filing

Total offering$285M

Investors in the raise48count reported to the SEC

FiledNov 21, 2025first sale Nov 12, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Christopher T. CainDirector

Garrett T. WinslowExecutive Officer

Carl T. GoldfischerDirector

Lori T. FirmaniExecutive Officer

Peter T. HarwinDirector

Amit T. MunshiDirector

Hans T. SchambyeExecutive Officer, Director

Jayson T. DallasDirector

Julianne T. BrunoDirector

Executive officers, directors and promoters as listed on the Form D.